BAG3 elevation inhibits cell proliferation via direct interaction with G6PD in hepatocellular carcinomas
PDF | HTML | How to cite
Metrics: PDF 1874 views | HTML 2223 views | ?
De-Hui Kong1,2, Si Li1, Zhen-Xian Du3, Chuan Liu4, Bao-Qin Liu1, Chao Li1, Zhi-Hong Zong1, Hua-Qin Wang1,2
1Department of Biochemistry and Molecular Biology, China Medical University, Shenyang, China
2Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, China
3Department of Endocrinology and Metabolism, The 1st Affiliated Hospital, China Medical University, Shenyang, China
4Department of Gynecology and Obstetrics, Shengjing Hospital, China Medical University, Shenyang, China
Hua-Qin Wang, e-mail: [email protected]
Keywords: BAG3, HCCs, G6PD, pentose phosphate pathway
Received: April 26, 2015 Accepted: November 14, 2015 Published: November 26, 2015
Bcl-2 associated athanogene 3 (BAG3) contains multiple protein-binding motifs to mediate potential interactions with chaperons and/or other proteins, which is possibly ascribed to the multifaceted functions assigned to BAG3. The current study demonstrated that BAG3 directly interacted with glucose 6 phosphate dehydrogenase (G6PD), the rate-limiting enzyme of the pentose phosphate pathway (PPP). BAG3 suppressed the PPP flux, de novo DNA synthesis and cell growth in hepatocellular carcinomas (HCCs). The growth defect of HCCs with forced BAG3 expression can be rescued by enforced G6PD expression. However, BAG3 elevation did not cause a reduction in cellular NADPH concentrations, another main product of G6PD. In addition, supplement of nucleosides alone was sufficient to recover the growth defect mediated by BAG3 elevation. Collectively, the current study established a tumor suppressor-like function of BAG3 via direct interaction with G6PD in HCCs at the cellular level.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.